Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cohen syndrome (CS) is a rare genetic developmental disorder characterized by microcephaly, characteristic facial features, hypotonia, non-progressive intellectual deficit, myopia and retinal dystrophy, neutropenia and truncal obesity.
Features include always present findings: Short stature, Low muscle tone (hypotonia), Narrow palm, and Thick vermilion border and others; and very common findings: Bone spicule pigmentation of the retina and Nyctalopia. 59 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 6 | Macrodontia of permanent maxillary central incisor, Facial hypotonia, Microcephaly |
VPS13B function has not been fully characterized.
Cohen syndrome is caused by mutations in the VPS13B gene on chromosome 8.
No clinically relevant genotype-phenotype correlations have been identified.
No consensus clinical diagnostic criteria for Cohen syndrome have been published.
Cohen syndrome should be suspected in probands with the following clinical findings and family history.
Clinical findings
Non-progressive global developmental delay/ intellectual disability
No approved treatments are currently available for Cohen syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for Cohen syndrome have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with Cohen syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 7. Cohen Syndrome: Recommended Surveillance
No clinical trials have been registered for Cohen syndrome.
26 publications have been identified in PubMed for Cohen syndrome. Research spans Case Report / Case Series (38%), Basic Science / Preclinical (31%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 38% |
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 12:49 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Cohen syndrome
Brain and nerves |
5 |
Seizure, Intellectual disability, Global developmental delay |
Muscles | 4 | Low muscle tone (hypotonia), Facial hypotonia, Damage to the optic nerve (optic atrophy) |
Bones and joints | 4 | Excessive inward curve of the lower back (lumbar hyperlordosis), Joint hypermobility, Thoracic scoliosis |
Eyes | 3 | Damage to the optic nerve (optic atrophy), Pigmentary retinopathy, Visual impairment |
Growth and development | 2 | Short stature, Decreased response to growth hormone stimulation test |
Arms and legs | 2 | Tapered finger, Narrow foot |
Blood and immune system | 2 | Low white blood cell count (decreased total leukocyte count), Decreased total neutrophil count |
Hormones | 2 | Decreased response to growth hormone stimulation test, Delayed puberty |
Digestive system | 1 | Feeding difficulties in infancy |
Pregnancy and birth | 1 | Neonatal hypotonia |
Heart and blood vessels | 1 | Mitral valve prolapse |
Age of onset: childhood.
To date, more than 300 individuals have been identified with biallelic pathogenic variants in VPS13B [, , , , , , ]. The following description of the phenotypic features associated with Cohen syndrome is based on these reports. Phenotypic features of Cohen syndrome are variable and include developmental delay, hypotonia, progressive retinal dystrophy and myopia, acquired microcephaly, joint laxity, characteristic facial features, truncal obesity, cheerful disposition, and neutropenia. The spectrum of these clinical findings ranges from severe to milder. Note: Certain statistics presented here are from the National Cohen Syndrome Database (NCSD) in which approximately 50% of individuals are Old Order Amish; the diagnosis of Cohen syndrome has been confirmed by molecular genetic testing in most individuals [H Wang, personal observation]. Table 2. Cohen syndrome: Frequency of Select Features
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Developmental delay/ intellectual disability | 100% | Non-progressive; severity varies even between sibs |
Hypotonia | 90%-100% | Improves over time |
Microcephaly | 90%-100% | Develops during or after 1st yr of life |
Neutropenia | 90%-100% | Neutropenia may be overlooked or diagnosed in early infancy. |
Progressive high myopia | 90%-100% | — |
Retinal dystrophy | 90%-100% | Range reflects that some younger persons may not have reached the age that retinal dystrophy is typically diagnosed. |
Truncal obesity | 80% | Appearing in or after mid-childhood w/rapid onset |
Neurobehavioral/psychiatric manifestations | 75% | Cheerful friendly disposition |
Short stature | 65% | Hypotonia. Half of mothers whose children are included in the NCSD recalled reduced fetal movement during an otherwise normal pregnancy. Most newborns with Cohen syndrome are hypotonic; feeding and breathing difficulties, likely related to hypotonia, are common during the first days of life. |
Developmental Milestone | Age at Milestone Achievement Finnish Cohort1 | English Cohort2 |
Roll over | 4-12 mos | -- |
Sit independently | 10-18 mos | 12 months |
Walk independently | 2-5 yrs | 2.5 yrs |
Speak first words | 1-5 yrs | 2.5 yrs |
Speak in sentences | 5-6 yrs | 5 yrs |
Source: GeneReviews — "Cohen Syndrome"
Retinal dystrophy appearing by mid-childhood
Progressive high myopia
Acquired microcephaly
Neutropenia
Imaging findings. Brain MRI is typically normal. Family history is consistent with autosomal recessive inheritance (e.g., affected sibs and/or parental consanguinity). Absence of a known family history does not preclude the diagnosis.
The diagnosis of Cohen syndrome is established in a proband with and biallelic pathogenic (or likely pathogenic) variants in VPS13B identifi...
Source: GeneReviews — "Cohen Syndrome"
Several disorders share clinical features with Cohen syndrome, particularly in the first year(s) of life. Disorders suspected in individuals later diagnosed with Cohen syndrome include those in . Table 4. Cohen Syndrome: Differential Diagnosis
Gene(s)/ Genetic Mechanism | Disorder | MOI | Clinical Characteristics | Features of Disorder Distinguishing From Cohen Syndrome |
|---|---|---|---|---|
~26 genes incl:ARL6BBS1BBS10BBS12BBS2BBS4CEP290MKKS | Bardet-Biedl syndrome (BBS) | AR | Cone-rod retinal dystrophy; Truncal obesity; Postaxial polydactyly; Cognitive impairment; Hypogonadotropic hypogonadism /or genitourinary malformations; Renal dysfunction | Postaxial polydactyly; Hypogonadotropic hypogonadism /or genitourinary malformations |
Renal dysfunction 1.5- to 1.8-Mb heterozygous deletion of WBSCR at 7q11.23 | Williams syndrome (WS) | AD1 | Cardiovascular disease; Distinctive facies; Connective tissue abnormalities; ID (usually mild), a specific cognitive profile, unique personality characteristics; Growth abnormalities; Endocrine abnormalities; Hypotonia hyperextensible joints | Cardiovascular involvement (not common in Cohen syndrome) |
Endocrine abnormalities Abnormal DNA methylation w/in PWCR at 15q11.2-q13 | Prader-Willi syndrome (PWS) | See footnote 2. | Severe hypotonia feeding difficulties in early infancy; In later infancy/ early childhood, excessive eating , unless eating is externally controlled, gradual development of morbid obesity; Delayed motor milestones language development; ID; Hypogonadism is common. | Absence of retinal dystrophy; Period of weight gain is assoc w/excessive eating. |
Different facial features Chromosome 5p deletion | Cri-du-chat syndrome (OMIM 123450) | See footnote 3. | Cardiac defects; Microcephaly; Hypotonia; Severe ID; Slow growth; High-pitched cat-like cry; Characteristic facial features | Cardiovascular involvement (not common in Cohen syndrome) |
Different facial features Deficient expression or function of maternally inherited UBE3A allele | Angelman syndrome (AS) | See footnote 2. | Severe DD or ID; Severe speech impairment; Gait ataxia /or tremulousness of the limbs; Unique behavior w/inappropriate happy demeanor that includes frequent laughing, smiling, excitability; Microcephaly seizures are common. | Seizures gait ataxia are not common in Cohen syndrome. |
Source: GeneReviews — "Cohen Syndrome"
Genetic testing for VPS13B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Cohen syndrome has been reported in the published literature.
Table 5.
Cohen Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Eval by primary care physician | • Eval for growth hormone deficiency
Nutritional assessment
| Neurologic eval | • Consider EEG if seizures are a concern.
Consider brain MRI if indicated.
| Orthopedics/ physical medicine rehab/ PT OT eval | Assess:
Spine for kyphosis scoliosis;
Gross motor fine motor skills;
Mobility, ADL, need for adaptive devices;
Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills).
| Neuropsychiatric eval | • For persons age 12 mos: screening for concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD
For adults: assessment for aggression self-injury
Source: GeneReviews — "Cohen Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Cohen Syndrome"
View trials for Cohen syndrome
Evaluation |
|---|
Frequency |
|---|
Development | Monitor developmental progress educational needs. | At each visit |
Epilepsy | For those w/known seizures: per treating neurologist | Per treating clinicians For those w/o known seizures Poor weight gain/ Growth deficiency |
Scoliosis/Kyphosis | For those w/known spinal issues | Per treating clinicians For those w/o known spinal issues |
Ophthalmologic involvement | Exam to assess visual acuity, refractive error, cataracts glaucoma in older persons, /or retinal dystrophy | Annually or per treating ophthalmologist Low vision services |
Neutropenia | Assess for neutropenia w/complete blood count differential. | Annually; more frequent monitoring may be needed for persons w/lower ANC or more frequent infections |
Gastrointestinal | Monitor for constipation. | At each visit Respiratory |
Source: GeneReviews — "Cohen Syndrome"
Phenotype severity distribution: 24 always present features, 2 very common features, 2 common features.
Estimated prevalence: Unknown (Unknown prevalence).
8 |
31% |
Research summaries | 4 | 15% |
Disease patterns and progression | 3 | 12% |
Testing and diagnosis research | 1 | 4% |
Lee SK (2026). [PMID: 42104376](https://pubmed.ncbi.nlm.nih.gov/42104376/). *Mol Brain*. [Basic Science / Preclinical]
Vacca F (2026). [PMID: 41522673](https://pubmed.ncbi.nlm.nih.gov/41522673/). *Tremor and other hyperkinetic movements (New York, N.Y.)*. [Epidemiology / Natural History]
Matsumura R (2026). [PMID: 41730960](https://pubmed.ncbi.nlm.nih.gov/41730960/). *Scientific reports*. [Basic Science / Preclinical]
Zhang K (2026). [PMID: 41591480](https://pubmed.ncbi.nlm.nih.gov/41591480/). *Acta diabetologica*. [Case Report / Case Series]
Lee SK (2025). [PMID: 41402289](https://pubmed.ncbi.nlm.nih.gov/41402289/). *Nature communications*. [Basic Science / Preclinical]
Kasmi Z (2025). [PMID: 39779505](https://pubmed.ncbi.nlm.nih.gov/39779505/). *Immunol Res*. [Epidemiology / Natural History]
Tekmenuray-Unal A (2025). [PMID: 41257743](https://pubmed.ncbi.nlm.nih.gov/41257743/). *Molecular cytogenetics*. [Case Report / Case Series]
Mital R (2025). [PMID: 41049620](https://pubmed.ncbi.nlm.nih.gov/41049620/). *CASE (Philadelphia, Pa.)*. [Case Report / Case Series]
Xu X (2025). [PMID: 41645382](https://pubmed.ncbi.nlm.nih.gov/41645382/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Case Report / Case Series]
Rotulo GA (2025). [PMID: 41390316](https://pubmed.ncbi.nlm.nih.gov/41390316/). *Pediatrics and neonatology*. [Review / Meta-Analysis]